TL;DR
This study reveals that profilin1 (Pfn1), a well-known actin-binding protein, plays a crucial role in controlling the levels of phosphoinositide PI(4,5)P2 in cells. Surprisingly, Pfn1 doesn't directly bind to PI(4,5)P2 at the plasma membrane as previously thought, but instead acts as a brake on the PI3K pathway, influencing the production of downstream signaling lipids like PI(3,4)P2 and PI(3,4,5)P3 by modulating the recruitment of the lipid phosphatase SHIP2.
What Problem Does This Paper Address?
Phosphoinositides (PPIs) are critical lipid signaling molecules that regulate a vast array of cellular processes, including actin dynamics, cell migration, and proliferation. While it's established that PPIs can influence the activity and localization of actin-binding proteins (ABPs) like profilin1 (Pfn1), the reverse — whether ABPs can actively regulate PPI signaling — has been less clear. Specifically, Pfn1 has been shown in vitro to bind to certain PPIs, leading to speculation that it might directly interact with them at the plasma membrane (PM) to modulate their levels. However, direct experimental evidence for this PM localization and interaction in living cells was lacking. This paper aims to clarify Pfn1's role in cellular phosphoinositide control, particularly its impact on PI(4,5)P2 homeostasis and its potential mechanisms of action at the PM.
Methods
The researchers employed a multi-pronged approach to investigate Pfn1's role:
- Live-cell imaging: They used a biosensor for PI(3,4)P2 (cPHx3-TAPP1 fused to EGFP) to monitor its PM accumulation kinetics in real-time following EGF stimulation in HEK-293 cells, both with and without Pfn1 depletion via siRNA.
- Immunostaining and lipid dot-blot assays: These techniques were used to assess total and PM-localized PI(4,5)P2 levels in various cell lines (MDA-MB-231, BT-474, HeLa, MCF10A) upon Pfn1 knockdown or overexpression.
- FRET-based assay: This was used to measure inositol trisphosphate (IP3) levels, serving as a readout for PLC-mediated PI(4,5)P2 hydrolysis, to determine if Pfn1 affects this pathway.
- CRISPR-Cas9 gene editing and split fluorescent protein system: To investigate Pfn1's PM localization, they endogenously tagged SHIP2 (INPPL1) with a split fluorescent protein (Neon Green) and used TIRF microscopy to track its PM recruitment upon EGF stimulation, with and without Pfn1 knockdown. They also generated an endogenously tagged mNG-Pfn1 cell line to assess its PM localization.
- FKBP-FRB chemical dimerization system: This system was used to acutely recruit various PPI-modifying enzymes (kinases and phosphatases) to the PM to see if this recruitment could induce Pfn1 localization.
- Proximity Ligation Assay (PLA): This was employed to detect endogenous Pfn1-SHIP2 interactions in cells, both under basal conditions and after EGF stimulation.
- Bioinformatic analyses: Alpha-fold predictions were used to explore potential interaction interfaces between Pfn1 and SHIP2.
Datasets
Not explicitly discussed as distinct datasets in the paper. The study relies on standard cell lines (HEK-293, MDA-MB-231, BT-474, MCF10A, HeLa) and established experimental protocols for cell culture, transfection, and imaging.
Key Insights and Ideas
- Pfn1 is a PI(4,5)P2 regulator, but not by direct PM binding: The study challenges the long-held assumption that Pfn1's interaction with PPIs occurs directly at the PM. Despite in vitro binding data, Pfn1 localization at the PM was found to be negligible, even when PPI-modifying enzymes were artificially recruited to the membrane.
- Pfn1 acts as a brake on the PI3K pathway: While Pfn1 depletion doesn't affect PI(4,5)P2 hydrolysis via PLC, it significantly enhances the production of downstream PI3K products like PI(3,4)P2 and PI(3,4,5)P3 upon growth factor stimulation.
- Pfn1 modulates SHIP2 recruitment: The enhanced PI(3,4)P2 production in Pfn1-depleted cells correlates with increased PM recruitment of SHIP2, a key enzyme in PI(3,4)P2 biosynthesis. This suggests Pfn1 indirectly controls SHIP2 localization.
- Pfn1 and SHIP2 interact, and this interaction is growth factor-regulated: PLA experiments revealed an endogenous interaction between Pfn1 and SHIP2, which is modulated by EGF stimulation. This interaction is proposed as a potential mechanism for Pfn1's restrictive role on SHIP2.
Key Results
- Pfn1 depletion leads to decreased cellular PI(4,5)P2 levels: Immunostaining and lipid dot-blot assays consistently showed reduced PI(4,5)P2 content in cells lacking Pfn1, and increased levels when Pfn1 was overexpressed.
- Pfn1 knockdown enhances PI(3,4)P2 PM accumulation: Live imaging of a PI(3,4)P2 biosensor in HEK-293 cells showed a significantly higher peak amplitude of PI(3,4)P2 at the PM after EGF stimulation when Pfn1 was depleted.
- Loss of Pfn1 does not affect PLC-mediated PI(4,5)P2 hydrolysis: FRET-based IP1 assays showed no significant difference in EGF-induced IP1 production between control and Pfn1-depleted cells.
- Pfn1 depletion enhances EGF-induced PM recruitment of SHIP2: TIRF microscopy revealed increased SHIP2 localization to the PM in Pfn1-knockdown cells following EGF stimulation.
- Evidence for Pfn1-SHIP2 interaction: PLA experiments detected endogenous Pfn1-SHIP2 interactions, which decreased upon EGF stimulation.
Limitations and Future Work
- Mechanism of Pfn1-SHIP2 interaction: While an interaction is detected, the precise molecular details and how EGF stimulation modulates it remain to be fully elucidated. The authors speculate it could be a direct binding event or an indirect effect mediated by the actin cytoskeleton.
- Pfn1's role in other PLC isoforms: The study focused on EGF-induced PI(4,5)P2 hydrolysis, primarily linked to PLCγ. The potential impact of Pfn1 on other PLC isoforms (PLCβ, PLCδ) activated by GPCRs was not investigated, though transcriptomic data suggests potential indirect effects.
- Direct demonstration of PM targeting: The study acknowledges that direct experimental evidence for Pfn1's binding to PM PPIs in actual cells is still lacking, and their findings suggest this is unlikely.
- Future directions: The authors suggest further studies using single-molecule imaging of endogenously tagged PTEN to investigate its PM localization and activity. They also propose exploring the role of Pfn1 in regulating RhoA activity and its downstream effects on PIP5K, as well as investigating the impact of Pfn1 on other PLC isoforms. Further research is needed to fully support the proposed models of Pfn1-SHIP2 interaction and its downstream effects.
Summary updated